Michelle L. Sorensen

Michelle L. Sorensen

Auto-generated profile, based on publicly available information

Michelle L. Sorensen

Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, Oregon, United States

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2024 in The Journal of Physiology
Verified
Journal Article
Closed access
MLMinghua Li
Minghua Li
MSMichelle Sorensen
Michelle Sorensen
MJMorgan A. Johnson
Morgan A. Johnson
SISusan L. Ingram
Susan L. Ingram
MAMichael C. Andresen
Michael C. Andresen
BHBeth A. Habecker
Beth A. Habecker

1 December 2024 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
ASArianna Scalco
Arianna Scalco
ELEthan N. Lee
Ethan N. Lee
MJMorgan A. Johnson
Morgan A. Johnson
MSMichelle L. Sorensen
Michelle L. Sorensen
THThomas N. Hilton
Thomas N. Hilton
BHBeth A. Habecker
Beth A. Habecker
Angiotensin II (ANG II)-induced hypertension leads to a heart failure phenotype and cardiac sympathetic denervation with the endocardial region of the left ventricle being the most affected. Denervation is accompanied by loss of norepinephrine content in the left ventricle and increased premature ventricular contractions (PVCs) after isoproterenol and caffeine injection. ANG II treatment also causes morphological changes in cardiac-projecting left stellate ganglion neurons.